clopidogrel and Lung Injury, Acute

clopidogrel has been researched along with Lung Injury, Acute in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Han, X	1
Hegeman, MA; Jongsma, G; Juffermans, NP; Müller, MC; Tuinman, PR	1
DiNicolantonio, JJ; Serebruany, VL; Sibbing, D	1
Kilpatrick, LE; Kunapuli, SP; Liverani, E; Rico, MC; Tsygankov, AY	1
Banerjee, A; Fragoso, M; Gamboni, F; Harr, JN; Jones, WL; Moore, EE; Silliman, CC; Stringham, J; Wohlauer, MV	1

Reviews

1 review(s) available for clopidogrel and Lung Injury, Acute

Article	Year
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond. Cardiology, 2014, Volume: 127, Issue:1 Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Sulfonamides; Ticagrelor; Ticlopidine; Transfusion Reaction	2014

Article

Year

Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.

Cardiology, 2014, Volume: 127, Issue:1

Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Sulfonamides; Ticagrelor; Ticlopidine; Transfusion Reaction

2014

Other Studies

4 other study(ies) available for clopidogrel and Lung Injury, Acute

Article	Year
Inhibiting P2Y12 receptor relieves LPS-induced inflammation and endothelial dysfunction. Immunity, inflammation and disease, 2022, Volume: 10, Issue:10 Topics: Acute Lung Injury; Claudin-5; Clopidogrel; Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; NF-kappa B; NF-KappaB Inhibitor alpha; Occludin; Proto-Oncogene Proteins c-akt; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Tumor Necrosis Factor-alpha	2022
High-dose acetylsalicylic acid is superior to low-dose as well as to clopidogrel in preventing lipopolysaccharide-induced lung injury in mice. Shock (Augusta, Ga.), 2013, Volume: 40, Issue:4 Topics: Acute Lung Injury; Animals; Aspirin; Blood Platelets; Bronchoalveolar Lavage Fluid; Clopidogrel; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Ticlopidine	2013
P2Y12 Receptor Modulates Sepsis-Induced Inflammation. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:5 Topics: Acute Lung Injury; Animals; Blood Platelets; Clopidogrel; Cytokines; Genetic Predisposition to Disease; Leukocytes; Lung; Male; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; P-Selectin; Phenotype; Platelet Activation; Platelet Aggregation Inhibitors; Pneumonia; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Sepsis; Signal Transduction; Ticlopidine	2016
Isoflurane prevents acute lung injury through ADP-mediated platelet inhibition. Surgery, 2012, Volume: 152, Issue:2 Topics: Acute Lung Injury; Anesthetics, Inhalation; Animals; Blood Platelets; Clopidogrel; Fluorescent Antibody Technique; Isoflurane; Lung; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Resuscitation; Shock, Hemorrhagic; Ticlopidine	2012